Lung Surfactants Market 2020-2027: Forecast, Trends
Lung
Surfactants Market, By Indication (Respiratory Distress Syndrome (RDS),
Respiratory Infections, Others), Drugs (Poractant, Beractant, Lucinactant,
Calfactant, Others), Route of Administration (Intratracheal, Injectable),
End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution
Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) –
Industry Trends and Forecast to 2029
GET
EXCLUSIVE SAMPLE COPY OF THIS REPORT HERE
Market Analysis and
Size
Lungs
surfactants Market are administered to prevent and treat neonatal respiratory
distress syndrome (RDS). RDS is a serious consequence of premature delivery
that affects over 40,000 infants in the United States and Canada every year.
The lungs eventually collapse due to low lung compliance caused by a functional
or quantitative surfactant deficit
Data
Bridge Market Research analyses that the lung surfactants market was valued at
USD 173 million in 2021 and is expected to reach USD 242.28 million by 2029,
registering a CAGR of 4.30% during the forecast period of 2022 to 2029. In
addition to the market insights such as market value, growth rate, market
segments, geographical coverage, market players, and market scenario, the
market report curated by the Data Bridge Market Research team also includes
in-depth expert analysis, patient epidemiology, pipeline analysis, pricing
analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report
Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units,
Pricing in USD |
|
Segments Covered |
Indication (Respiratory Distress Syndrome
(RDS), Respiratory Infections, Others), Drugs (Poractant, Beractant,
Lucinactant, Calfactant, Others), Route of Administration (Intratracheal,
Injectable), End-Users (Hospitals, Specialty Clinics, Homecare, Others),
Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy,
Others) |
|
Countries Covered |
U.S., Canada and Mexico in North America,
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy,
Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea,
Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of
Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South
Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of
Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as
part of South America |
|
Market Players Covered |
CHIESI Farmaceutici S.p.A. (Italy), ONY
Biotech Inc. (U.S.), Lyomark Pharma GmbH (Germany), Windtree Therapeutics,
Inc (U.S.), Aviva Systems Biology Corporation (U.S.), Boehringer Ingelheim
International GmbH. (Germany), AbbVie Inc. (U.S.), Abbott (U.S.) |
|
Market Opportunities |
·
Increase in the number of research and
development activities ·
Technological advancement |
Request Access for Lung
Surfactants Market:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lung-surfactants-market
Market Definition
Lung
surfactant is a crucial molecule in the organ. It helps to avoid pulmonary
edema by lowering surface tension in alveolar cells, which helps to stabilize
the alveoli. Phospholipids are present in lung surfactants, which are
synthesized from animal lung extract. Natural surfactant is a substance
produced by alveolar cells in the lungs that lines the alveoli and small
bronchioles, preventing them from collapsing. Lung surfactant helps oxygen pass
through the surface lining of the lungs and into the bloodstream.
Lung Surfactants Market Dynamics
Drivers
·
High
prevalence rate of respiratory infections
The
rise in prevalence rate of respiratory infections will act as a major driver
that will result in the expansion of the market's growth rate. Natural
surfactant has been recommended to treat lung diseases, including suspected
surfactant insufficiency in adults due to the promising outcomes obtained by
lung surfactants in treating respiratory failure in premature babies.
Increasing investment for
healthcare infrastructure
Another
significant factor influencing the growth rate of lung surfactants market is
the rising healthcare expenditure which helps in improving its infrastructure.
Also, various government organizations aims to improve the healthcare
infrastructure by increasing funding and this will further influence the market
dynamics.
Opportunities
·
Increase
in the number of research and development activities
Moreover,
the market's growth is fueled by an increase in the number of research and
development activities. This will provide beneficial opportunities for the lung
surfactants market growth.
Moreover,
the market's growth is fueled by investment to develop advanced technologies
and increase the number of emerging markets. These factors will provide
beneficial opportunities for the lung surfactants market growth.
Access Full Report :- https://www.databridgemarketresearch.com/reports/global-lung-surfactants-market
COVID-19 Impact on Lung Surfactants Market
The COVID-19 outbreak
and subsequent lockdown in numerous countries around the world had a huge
impact on the financial status of enterprises in all sectors. The private
healthcare sector is one of the areas where the pandemic had a significant
impact. As a result, the COVID-19 outbreak had impacted the economy by directly
influencing production and demand, causing distribution channel disruptions,
and having a financial impact on firms and financial markets.
Global Lung Surfactants Market
Scope
The lung
surfactants market is segmented on the basis of indication, drug, route of
administration, end-users and distribution channel. The growth amongst these
segments will help you analyze meagre growth segments in the industries and provide
the users with a valuable market overview and market insights to help them make
strategic decisions for identifying core market applications.
Indication
·
Respiratory Distress Syndrome (RDS)
·
Respiratory Infections
·
Others
Drugs
·
Poractant
·
Beractant
·
Lucinactant
·
Calfactant
·
Others
Route of Administration
·
Intratracheal
·
Injectable
End-Users
·
Hospitals
·
Specialty Clinics
·
Homecare
·
Others
Distribution Channel
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Pharmacy
·
Others
Competitive
Landscape and Lung Surfactants Market Share Analysis
The lung
surfactants market competitive landscape provides details by competitor.
Details included are company overview, company financials, revenue generated,
market potential, investment in research and development, new market
initiatives, global presence, production sites and facilities, production
capacities, company strengths and weaknesses, product launch, product width and
breadth, application dominance. The above data points provided are only related
to the companies' focus related to lung surfactants market.
Some
of the major players operating in the lung surfactants market are:
·
CHIESI Farmaceutici S.p.A. (Italy)
·
ONY Biotech Inc. (U.S.)
·
Lyomark Pharma GmbH (Germany)
·
Windtree Therapeutics, Inc (U.S.)
·
Aviva Systems Biology Corporation (U.S.)
·
Boehringer Ingelheim International GmbH. (Germany)
·
AbbVie Inc. (U.S.)
·
Abbott (U.S.)
Research
Methodology: Global Lung Surfactants Market
The key
research methodology used by DBMR research team is data triangulation which
involves data mining, analysis of the impact of data variables on the market,
and primary (industry expert) validation. Apart from this, data models include
Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide,
Company Positioning Grid, Company Market Share Analysis, Standards of
Measurement, Global versus Regional and Vendor Share Analysis. To know more
about the research methodology, drop in an inquiry to speak to our industry
experts.
Customization Available
Data
Bridge Market Research is a leader in advanced formative research. We take
pride in servicing our existing and new customers with data and analysis that
match and suits their goal. The report can be customized to include price trend
analysis of target brands understanding the market for additional countries
(ask for the list of countries), clinical trial results data, literature
review, refurbished market and product base analysis. Market analysis of target
competitors can be analyzed from technology-based analysis to market portfolio
strategies. We can add as many competitors that you require data about in the
format and data style you are looking for. Our team of analysts can also
provide you data in crude raw excel files pivot tables (Factbook) or can assist
you in creating presentations from the data sets available in the report.
Major TOC of the
Lung Surfactants Market Report
- INTRODUCTION
- MARKET
SEGMENTATION
- MARKET OVERVIEW
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- Lung Surfactants Market
- COMPANY PROFILE
- COMPONENT
MANUFACTURER
- CONCLUSION
- QUESTIONNAIRE
- RELATED REPORTS
Get TOC of the Report : https://www.databridgemarketresearch.com/toc/?dbmr=global-lung-surfactants-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market
Contact:
Data
Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse
Related Reports@
Cold
Compression Therapy Market

Comments
Post a Comment